Chemotherapy-induced thrombocytopenia occurs when chemo destroys platelet-producing bone marrow cells, increasing a person’s risk of dangerous bleeding. But the injectable drug romiplostim (Nplate) ...

CCSS follow-up of 24,886 five-year survivors (1970–1999 diagnoses) identified 471 individuals with 710 meningiomas, including frequent multiplicity (29% ≥2; 16% meningiomatosis).

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it alters gut bacteria and increases levels of a microbial molecule that travels to ...

A 49 year old woman was diagnosed with Philadelphia negative B-acute lymphoblastic leukemia (B-ALL) and subsequently started on induction chemotherapy with systemic cyclophosphamide, doxorubicin, ...

During and after cancer treatment with chemotherapy, up to 75 percent of people experience thinking and memory problems known as “chemo brain.” The cause of chemo rage can vary, says Dr. Cartagena, ...

FOX CHASE (WPVI) -- HIPEC is an often overlooked form of chemotherapy, with a long track record. It's improving survival rates in some abdominal cancers, however, some patients and doctors may not ...

Treatment with pembrolizumab and the antibody-drug conjugate (ADC) sacituzumab govitecan improved progression-free survival (PFS) in patients with PD-L1-positive locally advanced or metastatic ...

Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: The MIRAGE trial. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Chemotherapy doesn’t just kill cancer cells. It also affects the microbes in the digestive tract. Researchers at UC San Francisco have discovered that some gut bacteria can reduce the side effects of ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

The German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia (GMALL) B-ALL/NHL 2002 protocol achieved a 3-year overall survival and progression-free survival of 73% in adult patients with ...